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ABSTRACT
EFFECTS OF GLUTAMINE SUPPLEMENTATION ON MAXIMAL
PERFORMANCE AND RECOVERY FROM HIGH-INTENSITY EXERCISE

Mandy Lynn Jacobs
August 7, 2008
The purpose of this study was to determine the effects of acute glutamine
supplementation on maximal performance and recovery from high-intensity exercise. In
a placebo-controlled, crossover study, seven (six males and one female) healthy subjects
performed maximal treadmill exercise one-hour after the ingestion of 0.03 g·kg body
mass- 1 glutamine mixed with caffeine-free fruit juice or placebo. Expired gases,
respiratory exchange ratios (RER), heart rate (HR), ratings of perceived exertion (RPE)
and blood samples were collected pre-, during, and post-exercise. In addition, urine and
saliva samples were obtained pre- and post-exercise. No significant differences in
oxygen consumption, C02 production, HR, RPE, urine and saliva pH were found
between treatments. The GLN trial (1.20 ± 0.07) produced a higher RER value than the
PLC trial (1.11 ± 0.09) at 5-min post-exercise, resulting in a significant difference (p =
0.042). However, the significant difference was due to the inclusion of the female in the
group analysis. This study demonstrates that acute glutamine supplementation does not
enhance maximal performance or recovery from high-intensity treadmill running.
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CHAPTER!
INTRODUCTION
In today's culture, athletes are continuously searching for means beyond
traditional training techniques that will give them an additional advantage over their
competitors. Thus, athletes often rely on dietary supplementation in order to improve
their performance. Although limited information is available on the extent of dietary
supplement use among athletes, in 1999 it was estimated that the annual sales of
supplement products in the United States totaled $12 billion!. Athletes account for a
significant fraction of the total market and a wide range of products are aimed at both the
active population and at those engaged in competitive sport. The problem with this
reliance on dietary supplements is that the industry is completely unregulated by the
government in the United States due to the Dietary Supplement Health and Education Act
of 199457 . As a consequence, an abundance of supplement products of dubious value,
content and quality are now available to athletes all over the world 105. More recently
gaining popularity among athletes are individual amino acids- specifically, glutaminedue to its use in the area of human nutrition 133 • Results of clinical studies have suggested
that glutamine supplementation may improve nitrogen balance

54

and support immune

function! 02.
In a brief review of glutamine as a potential supplement for athletes, Antonio and
Street suggest that glutamine might provide ergogenic effects for athletes that engage in
intense exercise training4. They hypothesize that when athletes engage in high-intensity

exercise, a significant increase in plasma lactate and hydrogen ion (H+) concentration
occurs within the body due to glycolysis. This increased production ofH+ can cause a
fall in plasma pH from approximately 7.4 to 6.9-7.0, resulting in a state known as
metabolic acidosis (pH < 7.35). The associated fall in pH with acidosis can hinder
muscular contraction and ultimately performance by limiting the rate of resynthesis of
ATP by inhibiting key glycolytic enzymes, such as phosphfructokinase29 , 125; inhibiting
the release of calcium ions from the sarcoplasmic reticulum and the binding of these ions
to the protein troponin 33 , 37; and impairing the neural impulse propagation32, 124. Under
normal physiological conditions, glutamine is converted to a-ketoglutarate, which
produces ammonium ions (NH4 +) that in turn buffer the acidotic state. However, when
the decrease in pH is too drastic for this buffering system too work efficiently, such as
during high-intensity exercise, the athlete's performance and recovery may be
compromised56 .
Past studies have demonstrated that increasing plasma pH via sodium bicarbonate
·
.
.
.can
.Improve anaerob"IC exerCIse perlormance
c
92 ' 93 , 103, 144"15 18 ,
or sod mm
CItrate
mgestIOn
27,90,125. Hence some researchers have stated that it is logical to believe glutamine
supplementation would also be able to increase pH as well due to its base generating
potentiae, 56. However, very few studies have been conducted to investigate the effects
of glutamine supplementation on athletic performance and/or recovery from highintensity exercise3, 56,104. Making matters even more complicated, the studies have solely
examined the effects of glutamine supplementation on short intermittent bouts of
exercise, such as those observed during weightlifting3 and cycling (sprints)56, 104. No

2

reported literature was found examining the effects of glutamine supplementation on
maximal performance and recovery during high-intensity running.

Purpose of the Study
The purpose of this study was to determine if glutamine supplementation has an
ergogenic effect on high-intensity treadmill running.

Primary Aim:
1) To determine the effects of acute glutamine supplementation on plasma
glutamine concentration and lactate during and after a high-intensity running
protocol.

Secondary Aims:
1) To determine the effects of acute glutamine supplementation on maximal
performance (V02max) and associated parameters (ratings of perceived exertion,
heart rate, CO2 production) during a high-intensity running protocol.
2) To determine the effects of acute glutamine supplementation on recovery
parameters (02 consumption, CO 2 production, heart rate, respiratory exchange
ratio) after a high-intensity running protocol.
3) To further investigate the changes in plasma glutamine concentration during
and after high-intensity running.

Hypotheses
The following hypotheses will be tested:

Primary Hypothesis:
1) The acute supplementation of glutamine will increase plasma glutamine concentration
and decrease lactate levels during and after high-intensity running via a buffering effect.

3

Secondary Hypotheses:
1) The acute supplementation of glutamine will increase V02max and decrease
ratings of perceived exertion during exercise.
2) The acute supplementation of glutamine will increase CO2 production and

respiratory exchange ratios post-exercise.
3) Plasma glutamine concentrations will increase during and post-exercise from
resting (baseline) values.

Significance of Study
This study is significant as it will determine if acute glutamine supplementation
one-hour prior to exercise has an ergogenic effect on high-intensity running. Several
studies have indicated the use of oral glutamine supplementation to improve exercise
performance during high-intensity and prolonged exercise. To date no literature has
addressed the potential effects of glutamine supplementation on maximal performance
and recovery from high-intensity treadmill running. This research is important in
validating the use of glutamine supplementation prior to high-intensity running.

4

CHAPTER II
LITERATURE REVIEW

Glutamine is a five-carbon amino acid 76 that is found in the human body at
relatively high levels 117. In fact, glutamine is the most abundant non-essential amino acid
in human plasma

76

,

with normal plasma concentrations ranging between 500 and 750

).1mol/L40. There are two principal enzymes of glutamine metabolism: glutaminase and
glutamine synthetase. Glutaminase catalyses the hydrolysis of glutamine to glutamate
and ammonia, and glutamine sythetase catalyses the synthesis of glutamine from
ammonia and glutamate. The direction and rate of flux through the substrate cycle is
tissue-dependent, as different tissues vary considerably in the forward and reverse rates
of reaction. Therefore, the net direction of the reaction will determine whether a
particular tissue is a net consumer or producer75 , 97. A constant level is maintained under
normal conditions due to a balance between release and utilization of glutamine by
various organs within the body. By simultaneously sampling arterial and venous blood
various organs, one can classify an organ as either predominantly a consumer or a
producer of glutamine I 17 . Those organs considered to be involved in the synthesis of
glutamine include primarily skeletal muscle, the lungs, liver, brain and possibly adipose
tissue

l17

.

The main consumers appear to be the kidneys, intestines and cells of the

immune system40,75,97, 117. Under certain conditions, the liver may also become a net
consumer of glutamine I36.

5

Although numerous organs within the body use glutamine as a fuel, it is
prominently used by the immune system and gastrointestinal tract. In addition, glutamine
accounts for more than 60% of the total intramuscular free amino acid 122 and because
skeletal muscle represents a large mass of tissue, it is quantitatively the most important
site of glutamine synthesis despite the fact that glutamine synthetase activity is relatively
low per unit mass in skeletal muscle l40 .
Glutamine fulfills many vital roles in the tissues and organs of the body. Such
roles include maintenance of the acid-base balance during acidosis 28 ,46, 106, transfer of
nitrogen between organs and detoxification of ammonia

97

,

acting as a nitrogen precursor

for the synthesis of nucleotides 75, a fuel for gut mucosal cells 55 , 123, 145, 146 and cells ofthe
85
immune system7 and a possible direct regulator of protein synthesis and degradation .
As previously stated, plasma glutamine concentrations remain at constant level
under normal physiological conditions. Most naturally occurring food proteins contain
four to eight percent of their amino acid residues as glutamine, so the daily consumption
of glutamine is usually less than 10 gramsl22. However, during various catabolic states,
such as sepsis 9, surgerl4, 65,108, trauma, burns lO2 and acidosisl42, glutamine homeostasis
is placed under stress, and glutamine reserves are reduced. In addition, some studies
have shown similar states of depletion due to both prolonged and high-intensity exercise
stress 23 ,24. It has been suggested that it may be necessary to consume between 20 and 40
6
grams of glutamine per day to maintain homeostasis after a severe catabolic insule .

The Effects of Exercise on Plasma Glutamine Concentrations
Skeletal muscle is quantitatively the most important source of glutamine since not
23
only can it synthesize glutamine but it also provides storage . The store of free glutamine

6

within the skeletal muscle is estimated at 20 mmoliL of intracellular water I3, which
accounts for the majority of the body's total glutamine stores I22 . The rate of glutamine
synthesis in human skeletal muscle is higher than that for any other amino acid and in the
fed state is approximately 50 mmol/h44, 137. Parry-Billings et al. speculates that this high
synthetic rate is essential to maintain glutamine homeostasis due to the fact that skeletal
muscle provides the majority of glutamine required by other tissues lOo • Thus, it is
suggested that the failure of skeletal muscle to provide sufficient glutamine due to
exercise stress could result in a hindered performance and state of recovery.
Plasma Glutamine Measurement

Unlike the many other amino acids, glutamine has been shown to be relatively
unstable in aqueous solution95 and is known to readily break down to glutamate and
ammonia in the presence of heat, as well as either strong acidic or basic environmentS.
Specific preparations of samples and storage methods have been developed to minimize
degredation 117. To date, three different measurement techniques are primarily used for
the quantification of glutamine levels: enzymatic methodologyl, 35, 83,101, 118, 119, 146, 149,
high performance liquid chromatography (HPLC)IO, 12,30,36,47,68, 110, 115, and bioassay70,
116 . QuantI'fi catIOn
. 0f
l ' by enzyme assay mvo
. Ives converSIOn
. 0f
l ' to
g utamme
g utamme
glutamate83 , the subsequent degradation of the product to a-ketoglutarate at pH 9.0 14, and
the concomitant conversion of nicotinamide adenine dinucleotide (NAD+) to its reduced
form NADH, which is detected spectrophotometrically. The plasma level of glutamate is
then subtracted to obtain the original level of plasma glutamine, on the principal that the
conversion of glutamine to glutamate is on a molar to molar basis 117. Automated amino
l
acid analyzers have also been developed, based on this enzyme assal . HPLC has also
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been used to detennine plasma glutamine 10, 110 but generally require acidified samples in
analytical procedures 135 • The recently developed bioassay method, uses a strain of
Escherichia coli (E. coli) known to be dependent on glutamine for replication91 • Growth
of E. coli has been shown to be directly proportional to the amount of glutamine
available?o. The nonnal range of values obtained for human plasma samples differ to
some degree depending on the methodology used, thus it is important to consider which
methodology is being used when comparing particular studies with one another ll ?

Exercise & Plasma Glutamine Concentrations
There have been various studies that investigated the effects of exercise on plasma
glutamine concentrations (Table 1), although a clear consensus does not exist within the
literature. Data has shown that during exercise, plasma glutamine concentrations may
increase, decrease or remain unchanged depending on the type, duration, and intensity of
exercise. Walsh et al. feels the equivocal data is also due to the nutritional status of the
individuals and differences in measurement technique, blood sampling times and sample
storage 137 •
Prolonged Exercise
Studies that have analyzed the effects of prolonged exercise on plasma glutamine
concentration have led to ambiguous conclusions. In a recent experiment, continuous
cycling at 55% of maximal oxygen consumption (V02max) for three hours in 18 healthy
men led to a 23% fall in plasma glutamine one hour after exercise (580 /lmol/L preexercise compared with 447 /lmol/L after one hour ofrecovery)ll2. Producing similar
results, Rennie et al. monitored plasma glutamine levels for 270-minutes following 195minutes of cycling at 50% V0 2max llO . A fall from 557 /lmollL at rest to 470 /lmollL

8

immediately after exercise was reported. After two hours of recovery, plasma glutamine
levels continued to fall its' lowest level of391 Ilmol/L, but after 270-minutes of recovery,
levels increased to 482 IlmoliL 110. In addition, Parry-Billings et al. reported a 16%
decrease in mean circulating glutamine levels in 22 trained distance runners following a
marathon race (592 to 495 IlmollL)IOI.
In contrast, both a 30km treadmill run and cycle ride to exhaustion at 73%
V0 2max had no effect on plasma glutamine levels when samples were collected
immediately before and after exercise lOl • Similarly, Lehmann et al. reported no changes
in venous plasma glutamine concentrations following an ultra triathlon (7.5km
swimming, 360km cycling and 85km running)8o. However, in that study blood samples
were taken within 30 minutes of completing the race and it is possible that the glutamine
concentration may have decreased after this time 114. In addition, continuous cycling to
exhaustion at 80% V02max (which occurred within one hour) in 18 healthy men did not
alter the plasma glutamine level at exercise test cessation from the pre-exercise value ll2.
AcutelHigh-Intensity Exercise
Numerous studies have demonstrated an increase in plasma glutamine
concentration following brief (less than one hour) high-intensity exercise in humans.
Eriksson et al. found plasma glutamine levels increased from 538 Ilmoi/L to 666 IlmoliL
during 45-minutes of incremental exercise at 80% V02max

36

and Babij et al. observed

increases from 575 Ilmoi/L at rest to 734 IlmoliL during exercise at 100% V02 m ax

lO

•

These findings were further supported by a study conducted by Parry-Billings et al. in
which a series often six-seconds sprints resulted in an increase in plasma glutamine
levels from 556 IlmoliL pre-exercise to 616 Ilmol/L immediately post-exercise

9

JOI

. Hood

and Terjung claim that an increase in plasma glutamine concentrations during acute
exercise suggest that glutamate acts as a sink for NH3 in the formation of glutamine
during enhanced ammonia (NH3) production, which consequently occurs during highintensity exercise due to an increased reliance on anaerobic metabolism and an increased
production of lactic acid62 .
In contrast, Keast et al. found a significant decrease in plasma glutamine levels
due to acute high-intensity exercise. The study consisted of seven trained males that
participated in fifteen one-minute bouts at 90% V02max on a treadmill, which resulted in
a 44% decrease in plasma glutamine levels immediately after exercise. Additionally, the
same seven subjects showed a decrease of 55% immediately after participating in fifteen
one-minute bouts at 120% V02max on a treadmilCo. There has been one study to date
that has aimed to establish the pattern and time course of plasma glutamine recovery after
exercise and any diurnal variations. Kargotich et al. conducted a study in which eight
elite male swimmers completed IS x 100m intervals at 70% and 95% of their maximal
exercise intensity. Venous blood samples were obtained at rest, immediately postexercise and 30-minutes, 60-minutes, 120-minutes and ISO-minutes post-exercise. No
changes were observed in plasma glutamine following the 70% interval, however,
following the 95% interval, the means plasma glutamine concentration changed
significantly from 1140 /lmol/L at rest to 1002 /lmollL post-exercise. This data suggests
that at least six hours between intensive training sessions must be allocated to ensure
adequate plasma glutamine recovery. This study further emphasizes the necessity to
establish appropriate times within training programs to screen for specific training related
67

changes, as glutamine has been suggested as a marker of overtraining

10

•

Recovery from Exercise
Similar to the changes that occur during exercise, the return of plasma glutamine
levels to pre-exercise values during recovery (post-exercise) are dependent upon the
intensity and duration of the exercise bout. Decombaz et al. reported that the changes in
plasma glutamine levels observed in trained athletes following a 100km run had not
returned to pre-exercise values even after 24 hours of recoveri I, In addition, during a
225-minute exercise session at 50% V0 2max, a mean resting glutamine level of 557
~mol/L,
~mol/L

fell to 470

~mol/L

immediately after exercise and was further decreased to 391

after 120-minutes of recovery, It had increase to only 482

~mol/L

after 270

minutes of recovery I 10 , Similarly, in a study involving eight trained male swimmers
whom participated in fifteen one-minute bouts at 95% V0 2max, the lowest levels were
observed between four and six hours after exercise, 84 and 86% of the resting plasma
glutamine level respectively66, Consequently, it has been suggested that considerable
periods of recovery may be required between exercise training sessions, particularly those
of high-intensity exercise, to allow complete recovery of plasma glutamine levels ll7 ,
Moreover, following a triathlon in which eight volunteers swam 2,5km, cycled 81km and
ran 19km, mean serum glutamine levels declined from 468

~mol/L

(pre-race) to 318

~mol/L at two-hours post-exercisel1 4,

The fall in plasma glutamine observed post-exercise may be due to an increased
' by thek
d 'm attempt to b u f~ler metab 0 I'lC aCI'd'
96 141 , 143 ,
uptak e 0 f g1utamme
l 'neys
OSIS'
Acidosis can arise from increased lactic acid production associated with high-intensity
exercise and an accumulation of other organic acids including free fatty acids,
acetoacetate and 3-hydroxybutyrate, Ammonia production in the kidneys and its

II

secretion into the distal tubules together with excretion of excess protons in the urine
protects against acidosis. By the action of glutaminase, glutamine is hydrolyzed to
glutamate in the distal tubules, producing NH3, which can be combined with a hydrogen
ion to form ammonium ions

137

•

Alternatively, the immune system may be stimulated to

increase glutamine utilization as a result of exercise-induced early inflammation and
cytokine activation

109

, 121, concomitant with lymphocyte activation l9 and mobilization of

natural killer cells with an increased glutamine oxidation rate42 • It has also been
postulated that glutamine uptake by the liver and gastrointestinal tract for
gluconeogenesis occurs simultaneously with constant or decreased glutamine release by
muscle, resulting in a decreased post-exercise plasma glutamine concentration 137 •

Overtraining Syndrome
Given the changes in plasma glutamine levels that are commonly observed after
prolonged and/or high-intensity exercise and the function of glutamine in immune cells,
the role of glutamine in overtraining has recently gained attention52 • The Overtraining
Syndrome (OTS) has been defined as prolonged fatigue and under-performance
following periods of heavy training98 . The plasma concentration of glutamine has been
reported to be lower in overtrained athletes than in well trained athletes and sedentary
individuals 73,84,101,116. Rowbottom et al. observed a lower mean plasma glutamine level
in a group often athletes classified as overtrained (703

~mollL)

compared with sedentary

(1030 ~mol/L) and athletic age-matched controls (1179 ~mol/L)116.

While Parry-

Billings et al. reported mean plasma glutamine levels of 503 ~moliL in a group of 40
athletes diagnosed as having the OTS, compared with a mean level of 550
group of controls

101

~mol/L

. Plasma glutamate (the precursor to glutamine) levels were,
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in a

however, reported to be significantly higher (161

VS.

125 IlmollL) in the group suffering

from the OTS. In another study, glutamine responses in trained cyclists who completed
two weeks of intensified training were examined and while no significant changes in
glutamine were noted across the two week period, a decline in the glutamine/glutamate
ratio was found 53 . This relationship has also been noted by Smith and Norris who
hypothesize that glutamine concentration decreases when the volume of work exceeds the
athlete's capacity to tolerate work l2o . Various reasons have been suggested as the cause
of the decline in glutamine concentration over time, such as increased levels of
glucocortiocods 6, 81; decreased nutritional intake ofprotein82 ; mitochondrial lesions
within skeletal muscle 116; and increased rate of utilization of glutamine by other tissues
rather than decreased production l2o .
Exercise and the Acid-Base Balance

During high-intensity exercise, glycolytic energy production is elevated with a
concomitant increase in lactate (La-) and hydrogen ion concentration (H+) within the
working tissues 58 , 59, 74. Consequently, the accumulation of H+ results in a decrease in pH
which is thought to (a) reduce force production through hindered excitation-contraction
coupling34, 37, (b) inhibit glycolytic energy production25 , 125,129, and (c) decrease crossbridge cycling87 , 138. Therefore, it is believed that an artificially induced alkalosis
(increase in pH) may enhance performance by improving the buffering capacity of the
blood and tissues to withstand the decrease in pH associated with high-intensity
.

86

exercIse .
Past studies have demonstrated that an induced alkalosis (using sodium
bicarbonate or sodium citrate) can delay the onset of fatigue by buffering the

13

accumulation of H+ and aiding the efflux of lactate from contracting tissues during highintensity exercise lasting between 30-seconds and 4-minutes I5 , 18,27,90,92,93,103,125,144, In
one study, six trained male athletes were studied under control, sodium bicarbonate
(NaHC0 3) and placebo conditions to study the effect of induced alkalosis on 400-m
racing time, In the alkalotic condition the subjects ran significantly faster (1.52-sec) than
either the control or placebo conditions, In addition, the post-exercise pH, bicarbonate
and base excess levels were all lower in the alkalotic condition than in the others45 , Thus
suggesting that NaHC03 can be used an ergogenic aid by facilitating the efflux ofH+
from the skeletal muscles, Moreover, several investigators have reported a decrease in
perceived exertion III, 126, Sodium citrate ingestion has also been found to improve
anaerobic performance of l20-sec and 240-sec on a cycle ergometer by increasing
bicarbonate concentrations and decreasing pH levels 94 , However, some would argue that
the evidence for any ergogenic effect resulting from ingestion of alkanizers is equivocal.
Several authors found no improvement in the performance of high-intensity exercise
~ 11owmg
'
10

, 0 felt
' her so d"mm CItrate or sod'mm b'lcarbonate) 69 ' 72"78 The
th'
e mgestIOn

variation in findings may partially be explained by differences in the dosages of
alkalinizing agents and in the exercise intensity and duration II,
Dietary Influences on Plasma Glutamine Concentration

There is substantial evidence that dietary intake can influence plasma glutamine
levels43 , 49,89, 134, 148, Gleeson et al. investigated the relationship between carbohydrate
(CHO) intake and plasma glutamine; subjects exercised twice for 60-minutes at 70%
V02max: once after consumption of a normal diet and once after three days on either a
high (75%) or low (4%) CHO diet. Exercise after the low CHO diet resulted in a lower

14

post-exercise plasma glutamine concentrations when compared with the high CHO diet43 •
This is most likely due to resting metabolic acidosis, which has been shown to occur with
very low CHO diets

89

.

Circulating acidosis leads to an increased uptake of glutamine by

the kidneys for the purpose of buffering H+ and this reduces plasma levels of glutamine I 6.
In addition, glutamine is used as a gluconeogenic precursor I 17 and gluconeogenesis
increases when CHO availability is

IOW

I6

•

Similar results were discovered by Blanchard

et al. who investigated the relationship between muscle glutamine, muscle glycogen, and
plasma glutamine concentrations over three days of high-intensity exercise during which
CHO intake varied. Mean plasma glutamine concentration was significantly higher
during the 70% CHO exercise trial when compared to the 45% CHO trial. However,
glycogen decreased by the same magnitude during both trials and there was no
relationship between changes in plasma glutamine and changes in muscle glycogen
concentration. Because neither muscle glycogen nor muscle glutamine concentrations
differed between diets and exercise trials, the authors suggested that the lowered CHO
and increased protein intake (40% higher than that on the high-CHO diet) may have
increased removal of glutamine from the circulation l6 . These results are in agreement
with data of Zanker et aI., which showed that consumption of an 80% CHO meal before
intense endurance exercise resulted in higher glutamine levels compared with fasting for
14-hours before exercise l48 . Studies in rats also indicate that pre-exercise CHO
availability is an important factor, since 24-hour fasted rats exhibited a much greater fall
in plasma glutamine after 30-minutes swimming compared with the same exercise
performed in the fed state26 • In contrast, van Hall et al. reported that CHO
supplementation prior to and during exercise had no effect on plasma glutamine
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concentration during exercise and did not prevent the post-exercise decrease in plasma
glutamine 132.
Research has also shown that protein intake can influence plasma glutamine
concentration, as increases of plasma glutamine levels of up to 29% were observed
following meals

21

especially those with substantial protein content. Alternatively, it has

been demonstrated that a diet rich in protein (24% protein, 72% fat, 3% eRO) consumed
for four days results in a 25% lowering of muscle and plasma glutamine levels 50 .
Furthermore, in a study aimed at determining the relationship between resting plasma
glutamine concentration and dietary protein intake for athletes of different sports
(runners, swimmers, cyclists, nonathletes) dietary protein intake expressed relative to
body mass (g·kg·l·d- l) was significantly inversely related to plasma glutamine
concentration. This negative relationship may be explained by an increase in glutamine
uptake in the kidney, in an attempt to maintain acid-base balance in athletes consuming a
high protein diet 61 • Ammonia produced via the hydrolysis of glutamine to glutamate
binds to a hydrogen ion to form ammonium ion49 ,63, 117. In combination with an anion,
commonly chloride, ammonium is excreted in urine. In this way, the kidney is able to
effectively excrete excess protons, and thus prevent cell acidosis associated with a high
protein diet48,49.
Diurnal Variations of Plasma Glutamine Concentration
It is important to note that intra-individual plasma glutamine concentrations can
vary widely during the dal l . During starvation or an overnight fast, the supply of
glutamine from the intestinal lumen is reduced because the glutamine present in the
protein of the diet is mainly metabolized by the absorptive cells of the small intestine. It
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is believed that 50-60% of glutamine is utilized in this way40. Early studies shave
identified a diurnal variation in plasma total amino acid level38 , as well as a similar
variation for individual amino acids, including glutamine39 . Although dietary influences
may have been a major contributor in these studies, diurnal changes have been reported
in healthy young adults following an overnight fast

99

.

More recently, it seems that

studies examining possible diurnal variations in glutamine concentration have published
conflicting results. Plasma glutamine levels were monitored for a period of 2 I-hours in
four healthy volunteers (n = 4) with no dietary restrictions, which resulted in a plasma
glutamine increase two-hours after ingesting a meal containing protein. Castell et al.
reported that during a 2 I-hour fast there was almost no change in plasma glutamine levels
throughout the day, compared with the normal day (free of dietary restrictions), thus
suggesting the absence of diurnal variations. However, it should be noted that only one
subject participated in the 2 I-hour fast within the stud;

1
•

Glutamine Supplementation
Antonio and Street state that it would seem plausible that glutamine
supplementation may exert a beneficial effect for individuals engaged in chronic and
intense exercise training. They believe that because glutamine concentrations decline in
a dose-dependent manner 77, one could hypothesize that exercise training would increase
the requirements for glutamine such as that exogenous self-administration may be
necessary for ultimate performance and complete recovery4. Antonio and Street state
their hypothetical reasoning for glutamine supplementation by athletes on established
effects of exercise stress and glutamine. Since glutamine plays a crucial role in the
functioning of the immune system and its' cells, it may be suggested that glutamine
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supplementation may prevent or lessen severity of illness or infection after an intense
bout of exercise, thus enabling the athlete to resume intense training more quickly. In
addition, glutamine supplementation may offset catabolic effects of elevated
glucocorticoid levels that are produced during exercise. Moreover, the provision of
glutamine to fuel other organs (gastrointestinal tract, liver, kidney, and immune cells)
could spare the potential loss of glutamine due to inadequate dietary intake, thus sparing
muscle protein4 •
Of particular importance is the theoretical effect glutamine may have on the acidbase balance within the body by producing a buffering effect. It is suggested that
glutamine alters the acid-base balance by increasing plasma bicarbonate (HC03) retention
within the kidneys, via deamination, when glutamine enters the epithelial cells of the
.
. . 0f
l'
k1'dneys 139' 142 , 147 . The ammomum
th
at 'IS ~lormed fr om th e deammatlOn
g utamme,
then binds with a H+ to form an ammonium ion. This loss from the epithelial cell drives
the carbonic anhydrase reaction to yield HC03 and H+. The excess intracellular HC03
diffuses into the extracellular regions with a sodium ion and subsequently enters systemic
51

circulation

•

The ammonium ion combines with an anion (usually chloride) and is then

excreted in the urine

97

,

thus allowing the kidneys to effectively excrete excess protons

and protect the body from acidosis 46 . More simply, once glutamine is oxidized in the
Krebs cycle, it is transported into the kidneys to dispose of nitrogen and recycle the
carbon skeleton.
Although Ziegler et al. confirmed that acute oral glutamine ingestion did not show
any signs of toxicity in patients receiving glutamine for several weeks

l49

,

very few

studies have investigated the effects of glutamine supplementation on athletic
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performance and recovery from high-intensity exercise. One study performed by
Antonio and colleagues 3, aimed to determine if high-dose glutamine ingestion affected
weightlifting performance. In a double blind, placebo-controlled, crossover study, six
resistance trained men performed weightlifting exercises after ingestion of glutamine or
glycine (0.3 g·kg body mass-I) mixed with calorie-free fruit juice or placebo. One hour
after ingestion, subjects performed four total sets of exercise to momentary muscular
failure. The findings indicated that short-term ingestion of glutamine does not enhance
weightlifting performance in resistance-trained men. Antonio et al. further suggested that
future work should examine long-term supplementation of glutamine in athletes during a
competitive season3.
In a similar study, Haub et al. 56 investigated the potential of glutamine
supplementation to alter the acid-base balance of the blood and subsequently increase the
time to exhaustion during high-intensity exercise. The researchers based their
investigations on the theory that glutamine alters acid-base status by increasing HC03
retention in the kidneys. Ten trained males performed five exercise bouts on a cycle
ergometer at 100% V02peak. The first four bouts were 60-sec in duration, while the fifth
bout was continued to fatigue. Each bout was separated by 60-seconds recovery. The
I
exercise bouts were initiated 90-minutes after ingesting 0.03 g·kg body mass- of either
glutamine or placebo. Venous blood samples showed no significant difference in pH,
[HC03], and lactate concentration ([La-]) between pre-ingestion, pre-exercise, bout four
and bout five. In addition, time to fatigue was not significantly different between
conditions. Overall, the data indicated that acute glutamine ingestion did not enhance
either buffering potential or exercise performance in trained males. However, the
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researchers suggest that the environment may need to be acidic in order to activate
glutaminase (the enzyme responsible for the breakdown of glutamine in the kidney) and
ultimately use glutamine to increase HC0356 .
In a recent study Piattoly investigated the effects of glutamine supplementation on
recovery from intense exercise among elite cyclists. Specifically, the influence of
glutamine supplementation (0.3 g·kg body mass·! for six days) on time to exhaustion and
power after a prolonged bout of exercise was analyzed. The results showed no group
differences in V0 2peak, peak power and time to exhaustion before supplementation, and
participants in both the glutamine group and placebo group experienced similar declines
in performance immediately and 24-hours after an exhaustive bout of exercise. However,
it was discovered that participants in the glutamine group increased time to exhaustion
following six days of supplementation and appeared to recover from exhaustive exercise
earlier than those participants that did not ingest glutamine {placebo group)!04.
In addition, data showing low plasma glutamine and an increased occurrence of
upper respiratory tract infections in some groups of highly trained athletes has raised
interest in glutamine supplementation for those investigating immune function during
periods of intense training and post-exercise recovery137. One study specifically
examined a possible prophylactic effect of oral glutamine supplementation on the
occurrence of infection24 . Castell et al. gave ultra-marathon and marathon runners
participating in races either a placebo drink (malo-dextrin) or glutamine solution (5grams glutamine in 330mL of water) immediately upon completion and two-hours after
the race. Athletes were given questionnaires to self-report the occurrence of symptoms of
infection for seven days after the race. In those receiving the glutamine supplements (n =

20

72), 81 % experienced no infection in that period. In those receiving the placebo drink (n
=

79), only 49% experienced no infection in the same period. The authors concluded that

the provision of two glutamine drinks in the first two hours post-race decreased the
incidence of infection in the week after the event24 . Similarly, another study found that a
glutamine solution (0.1 g'kg body mass-I) given at 0, 30, 60, and 90-min following a
marathon race prevents the fall in plasma glutamine concentration 113.

Glutamine Absorption
In a glutamine supplementation study, Castell et al. found that after administering
glutamine, plasma glutamine concentrations increased by at least 50%, peaking at 30minutes after ingestion and remaining elevated for one to two-hours before returning to
the normal range of 500-700 JlmollL. Subjects were either given 0.1 or 5 grams Lglutamine per kilogram of body weight22 . In another study Ziegler found similar results
in whole blood. Rested subjects were given either 150-ml distilled water (zero glutamine
dose), 150-ml water containing O.l-gram glutamine per kilogram of body weight (low
glutamine dose) or 150-ml distilled water containing 0.3 g'kg body weight (high
glutamine dose). Whole blood concentrations of glutamine rose in proportion to
administered oral glutamine load. Blood glutamine levels peaked 30-45 minutes after
ingestion and then decline steadily to the normal range within 90-120 minutes (low dose)
or 180-240 minutes (high dose)149.

Summary
In summary, glutamine is an amino acid that is crucial for many important
homeostatic functions and for the functioning of a number of tissues in the body. During
various catabolic states including surgery, infection and acidosis, glutamine homeostasis
is placed under stress and glutamine reserves can become depleted. Similar to a catabolic
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stress, high-intensity exercise may result in an increase, decrease or no change in plasma
glutamine levels during and after exercise. The resulting changes have been found to be
dependent upon the type, duration and intensity of exercise. Based upon previous human
research studies of glutamine supplementation, some researchers believe glutamine has a
potential utility as a dietary supplement for athletes participating in high-intensity
exercise. The mechanism behind this potential has been suggested to be due to
glutamine's influence on the acid-base balance within the body. To date, only one study
has reported an ergogenic effect (specifically, an increased time to exhaustion) due to
glutamine supplementation, thus warranting additional research in this area in attempts to
elucidate the equivocal data.
The present study will add to the current literature by examining a comprehensive
set of variables, which include plasma glutamine, glutamate, alanine and lactate
concentrations before, during and after exercise. Of the three supplementation studies
previously mentioned, the study conducted by Haub et al. was the only one to analyze
any blood work throughout the testing protocol. Blood was analyzed for pH, La- and
HC03 concentrations at baseline, pre-exercise (90-minuntes post-ingestion), and after the
fourth and fifth bouts of exercise56 . The studies conducted by Antonio et al. and Piattolly
et al. did not collect blood samples at any time throughout data collection3, 104. By
collecting blood samples, we hope to gain a better understanding for how high-intensity
exercise influences plasma glutamine, glutamate, alanine and lactate concentrations
before, during and after exercise. In addition, we will be analyzing expired gases for
V02max, C02 production, and respiratory exchange ratios, which have not been looked
at in previous supplementation studies. We will also be utilizing a treadmill running
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protocol, which is a novel exercise testing modality, as previous studies have only
examined the effects of supplementation on weight lifting performance and cycling3 , 56,
\04.

More specifically, our study will be utilizing an exercise protocol that should rely on

a combination of aerobic and anaerobic pathways to produce energy as the protocol is
designed to induce fatigue within 8-14 minutes. This is in contrast to the exercise
protocols used in previous studies, which could be classified as purely anaerobic. Lastly,
our study will be taking into account the average dietary intake of each subject, which
despite recent literature demonstrating the influence high protein/low carbohydrate
consumption on plasma glutamine concentration, has not been considered in any of the
previous supplementation studies.
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CHAPTER III
METHODS

Subjects
Seven healthy subjects (six males and one female) between the ages of 18 and 30
participated in this study. The subjects participated in a minimum ofthirty minutes of
moderate to high-intensity aerobic exercise at least four days a week and were free of
metabolic, cardiovascular, and orthopedic limitations as determined through a selfreported health survey (Appendix A) and participation questionnaire (Appendix B).
Individuals taking supplements (e.g. creatine, amino acid) were excluded from the study.
Prior to participation, subjects were informed of potential risks and benefits, familiarized
with all testing procedures and asked to sign an informed consent (Appendix C) approved
by the Institutional Review Board of the University of Louisville. The descriptive
characteristics (mean ± SD) of the subjects were as follows: age (23.0 ± 1.0 yrs), height
(173.1 ± 8.2 cm), weight (74.5 ± 13.3 kg), BMI (24.7 ± 3.0 kglm

2
),

body fat percentage

(12.7 ± 7.1 %), resting systolic blood pressure (112.5 ± 8.2 mmlHg), resting diastolic
blood pressure (80.2 ± 6.4 mmlHg), and resting heart rate (72.2 ± 6.6 b·min-

I

).

Session 1
Subjects participated in three sessions. During the orientation session (session 1),
the research project and procedures were explained to the subject and consent was signed.
In addition, the general health and overall body composition of the subject was assessed
by obtaining each subject's height, weight, heart rate, blood pressure and skin fold
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measurements. Subjects were instructed to maintain current levels of exercise and to not
alter dietary habits for the duration of the study. Each subject was asked to complete and
tum in a three-day food diary before the first day of exercise testing. The food diary
included everything the subject consumed for three days (one weekend day and two week
days). Instructions to complete a three-day food diary and food logs were provided for
the subjects (Appendix D). Food diary data was then analyzed by Diet AnalysisTM
software (Version 7.0).

Session 1 Measurements
1. Height & Weight
Height was measured without shoes in centimeters. Weight was measured without
shoes to the nearest 0.5 pound.

2. Heart Rate
Heart rate was measured via radial artery pulse palpation. The pulse was counted for
15 seconds and then multiplied by four, to determine the per-minute heart rate.

3. Resting Blood Pressure
Resting blood pressure was measured with the subjects seated in a chair with their
feet on the floor.

4. Body composition
Body composition was determined using a three-site skin fold measurement. Skin
fold measurements were obtained at the chest, abdomen, and thigh for male subjects.
Measurements were obtained at the tricep, suprailiac, and thigh for female subjects.
Gender specific regression equations were then used to convert the sum of skin folds
to percent body fat

64

.
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Sessions 2 & 3(Exercise Testing Sessions)
Subjects then participated in two separate exercise testing sessions. Before the
first exercise testing session (session two), all subjects were assigned to one of two
treatment groups (Group A or Group B). Treatment order was randomly assigned and
subjects were not informed as to which treatment group they had been assigned. Group
A participated in the experimental (glutamine supplementation) condition during the
second session and the control (placebo) condition during the third session. Group B
participated in the control condition during the second session and the experimental
condition during the third session. All subjects participated in both the experimental and
control treatment, with a minimum of seven days between testing sessions.
For each exercise testing session, subjects were asked to abstain from exercise
and to fast (water only) for two-hours prior to reporting to the laboratory. Upon reporting
to the laboratory for the exercise testing sessions, height, weight, resting blood pressure
and heart rate were recorded. Next, a research registered nurse trained and credentialed
in intravenous catheter (IV) placement, prepared the subject for the blood draws. The
baseline blood sample was collected via an IV catheter that was inserted by the research
nurse. The subject was then instructed to consume 0.03 g'kg body mass-I of either
glutamine (Progressive Laboratories, Inc., Irving, TX) mixed with 250 ml of caffeine-free
fruit juice or 250 ml of placebo matched for caloric input (caffeine-free fruit juice). All
drinks were pre-mixed by a research assistant before the subject's arrival and to ensure
compliance, subjects were asked to consume the drink under the supervision of
laboratory personnel within ten-minutes. Once the assigned solution had been consumed
subjects rested for one hour in a sitting position.
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At the end of one hour, the research nurse obtained the second blood draw (60min post ingestion). Subjects then provided urine and saliva samples which were
analyzed using a pH test strip (Sigma, St. Louis, MO). Next, the subjects performed a
maximal exercise test on the treadmill and V0 2max was determined via indirect open
circuit spirometry (ParvoMedics, Sandy, UT). The Bruce treadmill protocol consisted of
incremental increases in workload and was designed to induce fatigue within 8-14
minutes (Appendix E)2. Ratings of perceived exertion (RPE) were obtained every three17

minutes using the Borg's Category Scale (Appendix F) and heart rate (Polar 610i HR
Monitor, Polar Electro, Finland) was recorded every minute throughout the exercise test.
Determination ofV02max was ascertained if the subject met two of the following
criteria: 1) A plateau in oxygen uptake (or failure to increase oxygen uptake by 150
mLimin) with increasing workload; 2) a respiratory exchange ratio (RER) 2:1.15; or 3) a
RPE of> 17 on the Borg 6-20 scale

6o

.

RER values are a ratio between the amount of

carbon dioxide produced and the amount of oxygen consumed by the body
(VC02/V02)20. In addition, the research nurse obtained blood samples every four-

minutes, resulting in a possible maximum of four separate blood draws (4-min exercise,
8-min exercise, 12-min exercise, 16-min exercise) during exercise. The actual number of
blood draws was unique to the subject and dependent upon the duration ofthe exercise
test.
Upon the completion of the exercise test, subjects immediately moved to a chair
while remaining connected to the metabolic cart for 10-minutes. After, the initial 10minute recovery period subjects were disconnected from the cart and then reconnected
for 5-minute intervals at 25-min and 55-min post exercise in order to obtain recovery data
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at 30-and 60-min post exercise. During the one-hour recovery period, heart rate (Polar
610i HR Monitor, Polar Electro, Finland) was recorded I-min post exercise, 3-min post
exercise, 5-min post exercise, IO-min post exercise, 30-min post exercise and 60-min
post exercise. An RPE value was also recorded upon completion of exercise. In
addition, blood samples were obtained 5-min post-exercise, lO-min post-exercise, 30-min
post-exercise and 60-min post exercise. At the commencement of the one-hour recovery
period, subjects provided urine and saliva samples which were analyzed for pH values.

Blood Draw Procedure:
Blood samples were collected pre-exercise, during exercise and post-exercise
testing. To collect multiple blood draws with minimal discomfort to the subject, an IV
catheter was inserted by the research nurse. The following procedure was used: Subjects
were asked to sit with either left or right arm resting on the table and a tourniquet was
applied by the research nurse. The subject's forearm was reviewed for the optimal site to
insert the IV. Once determined, the area was cleaned with an alcohol prep pad saturated
with 70% isopropyl alcohol. Depending on the subject's veins, either an 18-gauge or 20gauge IV catheter (Becton Dickinson, Sandy, UT) was inserted. An IV catheter
extension set (Baxter Health Care Corporation, Deerfield, IL) was connected to the end
of the IV and blood work was drawn using a 5-mL syringe. Once drawn, the IV was
flushed with 5-mL of 0.9% sodium chloride (saline solution) in order to maintain patency
and ensure there was no discomfort or adverse effects to the IV placement. Surgical tape
was used to secure the catheter to the subject's arm. The blood was then transferred into
a vacutainer blood collection tube with sodium fluoride potassium oxalate (5mg/4mg)
(BD Vacutainer®, Franklin Lakes, NJ). Blood was collected intermittently throughout
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each exercise testing session, resulting in a possible maximum often separate blood
draws (baseline, 60-min post ingestion, 4-min into exercise test, 8-min into exercise test,
12-min into exercise test, 16-min into exercise test, 5-min post exercise, 10-min post
exercise, 30-min post exercise, and 60-min post exercise) and no more than 80-ml of
blood was obtained from a subject during each exercise testing session.

Following the

initial blood draw, each subsequent blood draw began with drawing 3-ml of 'waste' fluid
(saline flush and blood) from the IV using a 5-mL syringe. This was followed by a
second syringe being used to withdraw approximately 5-ml of blood from the catheter
which was then transferred into a vacutainer blood collection tube with sodium fluoride
potassium oxalate (5mg/4mg). The IV was flushed with 5-mL saline solution to ensure
patency for future blood draws. The blood samples were given time to clot and then
centrifuged (Smith Kline Beechman Clinical Laboratories, Model 6500) at 3400 rpm for
approximately 20 minutes in order to separate the serum from the cellular components.
Serum was then pipette transferred into a micro centrifuge tube (Fischer Scientific,
Pittsburgh, PA) and stored at -80°C until ready for analysis. If during exercise, the
research nurse was unable to obtain a sufficient (3-mL) amount of 'waste fluid' and/or
blood, the sample was not obtained. If post-exercise, the research nurse was unable to
obtain a sufficient (3-mL) amount of 'waste fluid' and/or blood, the sample was collected
via venipuncture. A different venous site was used to draw blood using a 21-gauge
"butterfly needle" (Becton Dickinson, Franklin Lakes, NJ) and transferred into the
vacutainer blood collection tube with sodium fluoride potassium oxalate (5mg/4mg). The
"butterfly needle" was inserted after the site was cleaned with an alcohol prep pas
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saturated with 70% isopropyl alcohol and was immediately removed after collecting the
blood sample.

Statistical Analyses

SPSS (Version 16.0) was used for all statistical analyses with significance set at
p<O.OS. Basic descriptive statistics were calculated for all data and values are reported as
mean ± standard deviation. Dependent t tests were performed to assess differences
between means for the experimental (glutamine) and control (placebo) trials and are
reported as mean ± standard deviation (SD).
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CHAPTER IV
RESULTS

Oxygen Consumption
No significant difference was observed between treatments for V0 2max or postexercise oxygen consumption at any measurement time during recovery (Table 2).

CO 2 Production
No significant difference was found between treatments for CO2 production
(Table 3). Carbon dioxide values were recorded every 15-seconds during exercise,
however the values used for analyses were derived from an average of the second and
third minute of each completed stage of the protocol to ensure values represented a
physiological steady state. Since only one subject was able to complete Stage 5, only
stages 1 through 4 were included in the analyses. Post-exercise C02 production values
were not significantly different between treatments at any measurement time during
recovery.

Respiratory Exchange Ratio
Maximum respiratory exchange ratios (RER) during exercise and post-exercise
values are displayed in Table 4 for the seven subjects (six males and one female). No
significant treatment effect was observed for the maximum RER value during exercise,
nor for values at lO-min post, 30-min post and 60-min post-exercise. Significance was
observed between treatments for the RER value at 5-min post exercise, with the GLN
trial producing a higher RER value than the PLC trial (p = 0.042).
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Heart Rate
Heart rate responses during exercise and post-exercise are shown in Table 5. No
significant treatment effect was observed for heart rate during exercise or at any
measurement time post-exercise. Similarly, there was no significant difference observed
between treatments for heart rate immediately upon the completion of exercise.
Ratings of Perceived Exertion
Ratings of perceived exertion (RPE) responses can be found in Table 6. No
significant treatment effect was found for RPE at any time measurement during exercise
or immediately upon completion of exercise.
Urine & Saliva pH
The pH values for both urine and saliva pre- and post-exercise can be found in
Table 7. There was no significant difference between the two treatments.
3-Day Dietary Intake
Three-day dietary averages can be seen in Table 8 for the seven subjects (six
males and one female). Each subject's food diary was analyzed for 1) average intake of
carbohydrates, proteins, and fats (in kcal and percentage of total intake); 2) average daily
dietary intake in kcal; and 3) average intake of carbohydrates, proteins, and fats in grams.
Blood Analysis
All results pertaining to serum glutamine, glutamate, alanine and lactate
concentrations are currently pending analysis.
Gender Differences
When the one female subject was removed from all statistical analysis,
significance was no longer observed at 5-min post-exercise for RER. Similarly, no
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significant differences in 02 consumption, C02 production, RER, HR, RPE, and urine pH
were found between treatments at any measurement time (Tables 10-15). The pH values
for saliva pre- and post-exercise can be found in Table 15. No significant treatment
effect was observed for saliva pH pre-exercise, however, significance was observed
between treatments for post-exercise saliva pH, with the GLN trial producing a higher pH
than the PLC trial (p=0.025). Lastly, the three-day dietary averages for male subjects can
be found in Table 16.
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Table 1. Plasma ~lutamine concentration followin~ exercise in humans
Reference
Study
EX
Methodology
Changes in
Participants Intensity/Duration
plasma
glutamine level
(%)
After Recovery

EX
Continuous or intermittent high-intensity EX
ParrylORA
10 x 6 sec treadmill
Billings et
sprint
lol
al.
Sewell et
9 RM (2F)
60 sec treadmill
al.I 19
running at 20 kmIh

Robson et
al. 112

18 TM

Katz et al. 68

8RAM

van Hall et
al.132

8TM

van der
Schoor et
al. 131

8TM

Keast et
7O
a1.

7TM

Walsh et
136
al.

8TM

20 kmIh treadmill
run to exhaustion
Cycling to
exhaustion at 80%
V0 2max
Cycling to
exhaustion at 100%
V0 2max
3 min cycling at
50% W max and 6
min at 80% W max
alternated to
exhaustion
2 min cycling at
90% W max
alternated with 2
min at 50% W max
until exhaustion
15 x 1 min
treadmill exercise
at 90% V02max
15 x 1 min
treadmill exercise
at 120% V0 2max
20 x 1 min cycling
at 100% V02max
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Enzymatic (A)

ill

Enzymatic (G)

i5

Return to
baseline
at 5min
after

j14
Enzymatic (G)

13

i2 at 5h

HPLC

i26

i13 at
10min

Enzymatic (-)

19

116 at 2h

Enzymatic (-)

120

124 at2h

Bioassay

144

155

Enzymatic (G)

12

116 at 5h

Table 1 (cont.)
Prolonged light-moderate intensity EX
Parry22 T (20 M) Marathon;:::: 150
Billings et
12 TM
min
lol
al.
4TM
30 km self-paced
treadmill run

Rennie et
a.I 110
Babij et al. IU

4RAM

Eriksson et
al. 36

II RAM

Robson et
al. ll2

18 TM

Maughan &
Gleeson et
al. 88

5RAM

Decombaz
et ae l

8TM

8RAM

Cycling to
exhaustion ay 73%
V0 2max
3.75h cycling at
50% V0 2max
10 min incremental
cycling at 25, 50,
and 75% V02max
and to exhaustion
45 min incremental
cycling to 75%
V02max
Cycling at 55%
V02max for 180
min
90min cycling at
70% V02max
100 km run

Enzymatic (A)

116

i8

i8

HPLC

116

Column
chromatograph
y

i28

HPLC

124

Enzymatic (G)

111

130 at
2h
Return
to
baseline
at
IOmin
il2 at
Ih
123 at
Ih

Enzymatic (G)

13

Column
chromatograph
y
HPLC

116

1 at 24h

132 at
2500m swim,
120
2h
81km cycle, 19km
run
a = percentage difference from pre-exercise plasma glutamine level (not corrected for
plasma volume changes); A = asparaginase used to determine plasma glutamine; F =
female; G = glutamine; HPLC = high performance liquid chromatography; M = male;
RA = recreationally active but not specifically endurance trained; T = trained; W max =
maximal work rate attained during an incremental exercise test; i = increased; 1 =
decreased; EX = exercise

Rohde et
I 114
a.

8TM
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Table 2. V0 2 (ml/kg/min-l) during and post-exercise (mean ± SD)
GLN

PLe

p-value

V02max

61.5 ± 11.8

58.6 ± 10.1

0.065

5-minPV0 2

8.82 ± 1.73

9.12 ± 2.31

0.412

10-minPV02

7.61 ± 2.08

7.24 ± 1.00

0.414

30-minPV02

6.56 ± 2.37

6.05 ± 1.46

0.399

60-minPV02

4.94 ± 0.79

4.62 ± 1.09

0.557

V02 = volume of oxygen consumption; P = post-exercise. n = 7 (6 males and 1 female),
except for 30-minPV02 (n = 6; 5 males and 1 female).
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Table 3. C02 Production (L/min) during and post-exercise (mean ± SD)
GLN

PLC

p-va1ue

Stage 1

1.18 ± 0.27

1.14±0.18

0.581

Stage 2

1.77 ± 0.34

1.66 ± 0.32

0.362

Stage 3

2.93 ± 0.53

2.55 ± 0.57

0.167

Stage 4

4.37 ± 0.78

4.15 ± 0.65

0.483

5-minP

0.79±O.l8

0.76 ± 0.24

0.366

10-minP

0.53 ± 0.23

0.47 ± 0.12

0.237

30-minP

0.33 ± 0.16

0.31 ± 0.09

0.447

60-minP

0.27 ± 0.05

0.26 ± 0.03

0.613

Stage 1 = average of minutes 2-3; Stage 2 = average of minutes 5-6; Stage 3 = average of
minutes 8-9; Stage 4 = average of minutes 11-12; P = post-exercise. n = 7 (6 males and 1
female), except for 30-minP (n = 6; 5 males and 1 female).
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Table 4. Respiratory Exchange Ratio during and post-exercise (mean ± SD)
GLN

PLe

p-value

Max

1.13±0.04

1.13±0.07

0.944

5-minP*

1.20 ± 0.07

1.11 ± 0.09

0.042*

10-minP

0.91 ± 0.08

0.87 ± 0.08

0.122

30-minP

0.70 ± 0.08

0.72 ± 0.09

0.564

60-minP

0.73±0.10

0.76 ± 0.10

0.688

Max = maximal RER during exercise; P = post-exercise, n = 7 (6 males and 1 female),
except for 30-minP and 60-minP (n = 6; 5 males and 1 female), *p<0.05, significant
difference between treatments.
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Table 5. Heart Rate (b'min- l ) during and post-exercise (mean ± SD)

GLN

PLe

p-value

3-minE

110.1 ± 11.8

103.0± 16.4

0.379

6-minE

132.7 ± 13.4

127.4 ± 16.5

0.109

9-minE

158.8 ± 14.8

154.5 ± 16.8

0.462

12-minE

182.0 ± 8.54

172.6 ± 23.1

0.403

End

180.5 ± 8.26

181.8±5.81

0.579

1-minP

132.6 ± 12.7

132.3 ± 20.0

0.962

3-minP

113.1 ± 11.3

112.6 ± 10.3

0.875

5-minP

107.0 ± 8.30

107.0 ± 8.40

1.000

10-minP

104.1 ± 9.83

105.0± 10.8

0.773

30-minP

96.8 ± 11.9

92.2± 15.4

0.255

60-minP

82.8 ± 17.4

81.8±14.5

0.705

E = during exercise; End = upon completion of exercise; P = post-exercise, n = 7 (6
males and 1 female), except for 12-minE (n = 3 males), End (n = 6; 5 males and 1
female), 1-minP (n = 6; 5 males and 1 female), and 3-minP (n = 6; 5 males and 1 female).
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Table 6. Ratings of Perceived Exertion (mean ± SD)

GLN

PLe

p-value

3-minE

6.71 ± 0.75

6.57 ± 0.53

0.604

6-minE

8.86 ± 1.34

8.57 ± 1.71

0.654

9-minE

12.0 ± 1.73

11.5 ± 2.14

0.407

12-minE

15.2 ± 0.95

15.0 ± 3.26

0.854

End

18.0 ± 1.52

17.1 ± 1.86

0.356

E = during exercise; End = upon completion of exercise, n = 7 (6 males and 1 female),
except for 12-minE (n = 4 males).
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Table 7. Urine and Saliva pH Values (mean ± SD)
GLN

PLC

p-value

PreUrine

6.67 ± 0.S6

6.S0 ± 0.38

O.Sl1

PostUrine

6.11 ± 0.19

6.14 ± 0.37

0.80S

PreSaliva

6.74 ± 0.S2

6.77 ± 0.44

0.886

PostSaliva

6.91 ± 0.41

6.78 ± 0.33

0.200

Pre = I-hour post-ingestion, immediately pre-exercise; Post = I-hour post exercise; n = 7
(6 males and 1 female).
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Table 8. Average Dietary Intake from the Three-Day Food Diary (mean ± SD)
Mean± SD
Total (kcal)

3296.0 ± 1113.4

Carbohydrate (kcal)

1657.1 ± 593.3

Protein (kcal)

581.7 ± 162.7

Fat (kcal)

931.2 ± 376.0

Carbohydrate %

50.5 ± 6.7

Protein %

17.7±3.9

Fat %

28.1 ± 5.6

Carbohydrate (grams)

431.2± 166.7

Protein (grams)

145.4 ± 40.6

Fat (grams)

113.9 ± 60.5

n = 7 (6 males and 1 female)
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Table 9. Descriptive characteristics of male subjects (mean ± SD)
Mean±SD
Age (yrs)

23.1 ± 0.98

Height (cm)

175.6 ± 5.2

Weight (kg)

76.5 ± 13.4

BMI (kg/m2)

24.6 ± 3.3

BF(%)

10.6 ± 5.0

RSBP (mrnlHg)

113.0 ± 8.9

RDBP (mrnlHg)

80.6 ± 7.0

RHR (b'min- I )

73.3 ± 6.6

BMI = body mass index; BF = percentage of body fat; RSBP = resting systolic blood
pressure; RDBP = resting diastolic blood pressure; RHR = resting heart rate; n = 6.
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Table 10. V02 (mlIkglmin- 1) during and post-exercise for male subjects (mean ± SD)

GLN

PLC

p-value

V0 2max

62.3 ± 12.7

59.4 ± 10.9

0.109

5-minPV02

9.21 ± 1.53

9.60 ± 2.13

0.371

10-minPV02

8.08 ± 1.83

7.50 ± 0.80

0.237

30-minPV02

6.90 ± 2.49

6.36 ± 1.40

0.475

60-minPV02

4.86 ± 0.83

4.66 ± 1.19

0.745

V02 = volume of oxygen consumption; P = post-exercise, n = 6, except for 30-minP
(n=5)
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Table 1l.C02 Production (L/min) during and post-exercise for male subjects (mean
±SD)
GLN

PLC

p-va1ue

Stage 1

1.24 ± 0.25

1.18±0.15

0.553

Stage 2

1.84 ± 0.32

1.71 ± 0.32

0.401

Stage 3

3.02 ± 0.53

2.59 ± 0.62

0.195

Stage 4

4.48 ± 0.79

4.25 ± 0.65

0.547

5-minP

0.83 ± 0.16

0.80 ± 0.23

0.554

lO-minP

0.57 ± 0.23

0.49 ± 0.12

0.l44

30-minP

0.35 ± 0.18

0.32 ± 0.09

0.489

60-minP

0.27 ± 0.05

0.27 ± 0.03

0.937

Stage 1 = average of minutes 2-3; Stage 2 = average of minutes 5-6; Stage 3 = average of
minutes 8-9; Stage 4 = average of minutes 11-12; P = post-exercise, n =6, except for
30minP (n=5)
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Table 12. Respiratory Exchange Ratio during and post-exercise for male subjects
(mean ± SD)
GLN

PLe

p-value

Max

1.13 ± 0.04

1.13±0.08

0.945

5-min

1.18±0.04

1.10 ± 0.09

0.102

lO-minP

0.91 ± 0.08

0.85 ± 0.08

0.106

30-minP

0.69 ± 0.09

0.71 ±0.10

0.619

60-minP

0.73±0.10

0.79 ± 0.12

0.363

Max = maximal RER during exercise; P = post-exercise, n = 6, except for 30-minP (n =
5).
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Table 130 Heart Rate (bomin-I) during and post-exercise for male subjects (mean ±
SD)
GLN

PLC

p-value

3-minE

108.1 ± 11.6

108.1 ± 10.0

1.00

6-minE

130.1 ± 12.7

124.0 ± 15.1

1.08

9-minE

156.5 ± 14.7

152.5 ± 17.4

0.562

12-minE

182.0 ± 8.54

172.6 ± 23.1

0.403

End

179.6 ± 8.90

181.8 ± 6.49

0.435

I-minP

135.8 ± 1l.3

132.6 ± 22.4

0.690

3-minP

114.0 ± 12.4

112.6 ± 11.6

0.713

5-minP

107.1 ± 9.08

107.1 ± 9.19

1.00

lO-minP

103.5 ± 10.6

104.3 ± 11.7

0.814

30-minP

95.6 ± 12.6

91.5 ± 16.7

0.374

60-minP

84.1 ± 18.7

83.3 ± 15.3

0.790

E = during exercise; End = upon completion of exercise; P = post-exercise, n = 6, except
for 12-minE (n = 3), End (n = 5), I-minP (n = 5), and 3-minP (n = 5).
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Table 14. Ratings of Perceived Exertion for male subjects (mean ± SD)

GLN

PLC

p-value

3-minE

6.67 ± 0.81

6.50 ± 0.54

0.611

6-minE

8.67 ± 1.36

8.33 ± 1.75

0.661

9-minE

11.8 ± 1.83

11.3 ± 2.25

0.415

12-minE

15.2 ± 0.95

15.0 ± 3.26

0.854

End

18.7 ± 1.6

17.0 ± 2.00

0.272

E = during exercise; End = upon completion of exercise, n = 6, except for 12-minE (n =
4)
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Table 15. Urine and Saliva pH Values for male subjects (mean ± SD)
GLN

PLe

p-value

PreUrine

6.61 ± 0.59

6.51 ±0.41

0.734

PostUrine

6.13 ± 0.20

6.16 ± 0.40

0.809

PreSaliva

6.86 ± 0.45

6.90 ± 0.30

0.889

PostSaliva*

7.00 ± 0.37

6.80 ± 0.36

0.025*

Pre = I-hour post-ingestion, immediately pre-exercise; Post = I-hour post exercise; n = 6.
*p < 0.05, significant difference between treatments
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Table 16. Average Dietary Intake from the Three-Day Food Diary for male subjects
(mean ± SD)
Male
Total (kca1)

3545.8 ± 981.5

Carbohydrate (kca1)

1764.5 ± 570.7

Protein (kca1)

632.0 ± 102.5

Fat (kca1)

1024.1 ± 311.7

Carbohydrate %

49.8 ± 7.02

Protein %

18.0 ± 4.19

Fat %

29.3 ± 5.08

Carbohydrate (grams)

460.1 ± 162.4

Protein (grams)

158.0 ± 25.6

Fat (grams)

125.9 ± 56.6

n=6
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CHAPTER V
DISCUSSION
The aim of this study was to examine the effects of glutamine supplementation on
high-intensity exercise and recovery from exercise. More specifically, the primary
purpose was to determine if acute glutamine supplementation improved performance
during a high-intensity running bout on a treadmill by altering the acid-base balance
(buffering capacity) of the blood. No significant difference in V0 2max, HR, or RPE was
detected between the GLN and PLC trials. A secondary purpose was to determine if
glutamine supplementation improved recovery parameters one-hour post exercise. No
significant difference in HR, C02 production or RER was observed between trials. Thus,
results of this study demonstrated no significant difference in maximal treadmill running
performance or recovery between GLN and PLC treatments following acute glutamine
supplementation. Unfortunately, due to the pending analysis of all blood work, it is not
possible at this time to address the effects of high-intensity running on plasma glutamine,
alanine, glutamate and lactate concentrations during and post-exercise and consequently,
how acute glutamine supplementation mayor may not influence these parameters.
In this study, the only significant difference observed between the GLN and PLC
treatments when both male and female subjects were included in analysis, occurred
within the RER values at 5-min post exercise (p = 0.042). The GLN trial (1.20 ± 0.07)
produced a higher RER value than the PLC trial (1.11 ± 0.09), which indicates at 5-min
post-exercise subjects were producing greater amounts of C02 relative to the amount of
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02 consumed during the GLN treatment. During recovery from high-intensity exercise, it
is common that RER values increase due to the rise in lactic acid which consequently
gives rise to C02. CO2 is then eliminated from the body via the lungs, as the lactic acid
in the blood is buffered by forming H2C03. Although it would seem logical to contribute
the higher value in the GLN trial to an increased buffering capacity due to the
supplementation of glutamine, because this was the only RER value to show significance,
future research is warranted in this area.
No significant differences in oxygen consumption were observed between
treatments at maximal efforts during exercise or at any time throughout the one-hour
recovery period. However it should be noted that the difference between V0 2max (61.5
± 11.8 and 58.6 ± 10.1 mllkglmin for the experimental and control treatments,
respectively) was approaching significance at p = 0.065. Although this fails to meet the
established criterion for statistical significance (p < 0.05), it suggests that the subjects
tended to use less oxygen at maximal intensity during the GLN treatment. In addition, no
significant differences in heart rate, ratings of perceived exertion, C02 production, urine
and saliva pH were found between treatments.
The nutrient analysis from the three-day food diary for the six males and one
female showed that the subjects' average intake consisted of a diet that was 50.5 ± 6.7%
carbohydrate, 17.7 ± 3.9% protein and 28.1 ± 5.6% fat. Their average carbohydrate,
protein and fat intake were 1657.1 ± 593.3kcal, 581.7 ± 162.7 kcal, and 931.2 ±376.0
kcal, respectively, resulting in a total caloric intake of 3296.0 ± 1113.4 kcal. These
values indicate that on average the subjects consume what is considered a 'balanced' diet
for people who live an active lifestyle. According to the 2005 U.S. Department of

52

Agriculture's "Dietary Guidelines for Americans", acceptable macronutrient distribution
ranges (AMDR) are 45-65% carbohydrate, 20-35% fat and 10-35% protein l3O , The
subjects in this study displayed values that were within these recommendations, hence the
dietary habits of the subjects in the present study should not have influenced plasma
glutamine concentration before, during or post-exercise, as past studies43 , 49,89,134,148 have
only demonstrated that high protein/low carbohydrate and high carbohydrate/low protein
diets alter plasma glutamine concentration" However, at this point in time, we can only
speculate due to the pending blood analysis,
To our knowledge, no other studies have examined the effects of acute glutamine
supplementation on performance and recovery from a high-intensity running bout. This
study indicates that acute glutamine supplementation does not improve high-intensity
exercise performance or recovery of this type, The comprehensive lack of significant
differences between treatments could be contributed to numerous factors and without the
blood analyses it is difficult to determine the mechanism(s) supporting the performance
and recovery results,
High-intensity exercise brings about dramatic alterations in acid-base status of
intracellular and extracellular regions of working tissues56 , Previous work has
demonstrated that increasing the buffering capacity and pH of extracellular fluid and
'
~
dunng
' h'Igh'-mtensltyexerclse
,
, 27 ' 45 , 74 , 79, 107 , In add't'
perlormance
lIOn,
bl 00 d Improves
research indicates that L-glutamine has potential alkalinizing properties which may elicit
improvements in exercise performance l39, 142, Welbourne demonstrated that the oral
ingestion of 2-grams of glutamine significantly increased plasma bicarbonate (He03)
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concentration in nonnal, healthy subjects, thus indicating the use for glutamine as an
ergogenic aid

139

•

However, the results of this study do not support this theory.

It may be plausible that the administered dosage of glutamine (0.03 g·kg body

mass-I) one-hour prior to exercise may not have been a great enough dosage to increase
plasma glutamine concentrations. Castell et al. found that after orally administering 0.1
g·kg body mass-lor 5-grams glutamine, plasma glutamine concentrations increased by at
least 50%, peaking at 30-minutes after ingestion and remaining elevated for one to two
hours before returning to the nonnal range of 500-700 llmollL22. This is three times the
amount of glutamine administered in the current study. If there was not an increase in
plasma glutamine concentration post-ingestion, then the subsequent increase in plasma
HC03 concentration

l39

may not have occurred. However, in a study by Antonio et a1. 3,

similar perfonnance results were discovered despite to use of dosage ten times greater
than that used in the current study. Subjects were given 0.3 g'kg body mass-lone-hour
prior to perfonning four total sets of exercise to momentary muscular fatigue, yet no
ergogenic benefit was shown3.

More similar to our study, Haub et al.
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gave 0.03 g·kg

body mass-I, and 90-minutes after ingestion, subjects perfonned four bouts of 60 seconds
cycling at 100% V0 2 peak followed by a fifth bout to exhaustion. There was no
difference in perfonnance in the fifth bout between glutamine and placebo groups. It
should be noted that plasma glutamine and bicarbonate concentrations were not measured
in either of these supplementation studies 56 , 139. Since we did not investigate the changes
in plasma HC03 concentrations and do not currently know how plasma glutamine
concentrations responded to the study, it is impossible to detennine if this is an influential
factor at this point in time. There is also the possibility that an increase in HC03 may not
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have occurred because glutaminase, the enzyme responsible for the breakdown of
glutamine in the kidney to initiate HC03 production, was not in a highly active state l43 .
Furthennore, for glutamine to elevate HC03 the physiological environment may have to
be acidic. It has been demonstrated that endogenous L-glutamine shifts from a
component for purine and pyramidine fonnation to one of base fonnation in the kidney
during a state of metabolic acidosis lOl , 143. This supports the rationale that the
environment may need to be acidic in order to activate glutaminase and subsequently use
glutamine to increase plasma HC0 356 . In this study, subjects were not in a state of
metabolic acidosis prior to glutamine supplementation.

Gender Differences
Due to the fact that there was only one female in this study in comparison to six
males, we thought it was important to examine the results controlling for gender. As
previously stated, when the female subject was removed (n=6), no significant difference
between the two treatments was observed for 02 consumption, C02 production, RER,
RPE, HR, or urine pH. A significant treatment effect (p=0.025) was shown in the postexercise saliva pH, with the GLN trial producing a higher (more alkaline) value of7.00 ±
0.37 compared to a more acidic value of 6.80 ± 0.36 in the PLC trial. It is logical to
assume the more alkaline value in the GLN treatment may be due to the acute
supplementation of a potential alkanizing agent (glutamine) prior to exercise, yet more
research is needed to make a conclusive observation.
As expected, the dietary intake averages changed drastically when the female was
removed. The males' average intake consisted of a diet that was 49.8 ± 7.02%
carbohydrate, 18.0 ± 4.l9% protein and 29.3 ± 5.08% fat. Their average carbohydrate,
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protein and fat intake were 1764.5 ± 570.7 kcal, 632.0 ± 102.5 kcal and 10241.1 ± 311.7
kcal, respectively, resulting in a total caloric intake of3545.8 ± 981.5 kcal. Despite the
increase in total kcal, the male subjects still displayed values that met the AMDR's, thus
plasma glutamine concentrations should not have been influenced 130. To our knowledge
the literature has not suggested a gender difference in glutamine metabolism. However,
it seems plausible that dietary intake may influence glutamine metabolism and ultimately
plasma glutamine concentration as differences in fuel substrate utilization between males
and females have been observed during exercise. For a given relative work intensity, free
fatty acids compromise a greater proportion of the source of energy in woman than in
men, thus resulting in greater lipid utilization41 , 127, 128. It appears that there is a
connection between estrogen and increased lipid mobilization, such as estrogen's ability
to inhibit lipoprotein lipase (responsible for the breakdown oftriglycerides in the blood
stream for storage or fuel) or enhance epinephrine production, since a higher
concentration of epinephrine increases the activity of hormone sensitive lipase
(responsible for adipose tissue lipolysis)8. It has also been shown that muscle glycogen
(storage form of carbohydrate that is located within the muscle cell) depletion is 25%
greater in males compared with females when subjects were matched for training status
and performance 127 • This is in agreement with females having a greater reliance on fats
as fuel during exercise.

Limitations
The most obvious limitation to this study was the lack of blood analysis and
hence, plasma glutamine, glutamate, alanine and lactate measurements. Without these
measurements it was very difficult to assess the effectiveness of glutamine as an
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ergogenic aid based upon a theoretical buffering capacity. Another limitation to this
study was the small sample size (n = 7; n

=

6, when female excluded) to detect

differences between the GLN and PLC treatment. Power and sample size analyses for
each variable for n = 7 and n

=

6 (males only) can be found in Appendix G. The exercise

protocol is another potential limitation because previous studies used different modalities
(strength training and cycling), durations, and intensities of exercise to examine the
effects of glutamine supplementation 3, 56, 104 which makes it difficult to compare results.
Furthermore, the blood draw procedure used during testing proved to be problematic as it
was often difficult to obtain the desired amount to blood from the subject, especially
during exercise. This is most likely due to the fact that during exercise, blood is
redirected away from areas were it is not needed (i.e. forearms) and to the working
muscles. Lastly, the lack of diet logs prior to reporting to the lab on testing days could
have been another possible limitation, as subjects were not asked to report what they
consumed on exercise testing days. Although, all subjects reported to the lab after a twohour fast, it might have been beneficial to use a control meal to exclude the possibility of
a high-proteinllow-carbohydrate or high-carbohydrate/low-protein meal influencing
plasma glutamine concentrations.

Future Research
The findings from our research suggest that other research could be conducted to
better understand the effects of acute glutamine supplementation on high intensity
exercise and recovery from exercise. Future studies should examine the changes that
occur during and post-exercise to plasma glutamine, glutamate, alanine, HC03, pH and
lactate values. Studies should also examine the effects of acute supplementation at
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various dosages on perfonnance and recovery parameters, such as V02max, RER, C02
production, heart rate, and ratings of perceived exertion. Research is also warranted in
the area of long-tenn glutamine supplementation for athletes participating in numerous
high-intensity perfonnances separated by only a few hours, as supplementation may
allow for a more favorable acid-base status prior to subsequent perfonnances.
Summary
In summary, this study demonstrated no significant difference in maximal
treadmill running perfonnance between GLN and PLC treatments following acute
glutamine supplementation. Although, there was a significant difference in the 5-min
post-exercise RER value this was due to the inclusion of the female in the group analysis.
More research is needed to make a conclusive observation about the effects of acute
glutamine supplementation on recovery from high-intensity exercise. Therefore, the
potential of acute glutamine supplementation as an ergogenic aid due to an increased
buffering capacity has yet to be observed.
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APPENDIX A
THE UNIVERSITY OF LOUISVILLE
EXERCISE PHYSIOLOGY LABORATORIES

Health Survey
Name_ _ _ _ _ _ _ _ _ _ _ _ _ _ Local Phone_ _ _ _ _ _ _ _ __
Local Address, _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
Today's Date_ _ _ _ _ _ __
Age _ _ _ __

1.

Birth date _ _ _ _ _ _ __

Sex_ _ __

Weight_ _ _ Height_ _ __

Have you ever been diagnosed as having any of the fol/owing (if there is a family history
of any of the fol/owing, please check the Family History column)?

Never

In Past

Presently Family History

a. Heart Diseases
b. Rheumatic Fever
c. High Blood Pressure
d. Hemophilia
e. Other Vascular Disorders
f. Diabetes
g. Kidney Disease
h. Liver Disease
i. Asthma
j. Allergies (in general)
k. Chronic Bronchitis
1. Other Respiratory Illness
m. High Serum Lipids
n. Anemia
o. Low Blood Sugar
p. Neuro-Musculo-Skeletal Problems
2.

Please indicate any surgery that you have undergone and the approximate date(s):

3.

Please indicate recent illnesses or major injuries that you have had & the approximate

date(s):

4.

5.

Please list any and aI/ medications that you are presently taking:
Medication
Dosage

Do you smoke? _ _ __

Packs per day
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Dosage per day

6.

Describe your present training program (the activity, amount per day, days per week, and

the length of time you have been training at this level):

Activity

Minutes/Day

Days/Week

Weeks of Training

The information provided above is correct to the best of my knowledge:

Signature

Date
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APPENDIXB
Subject Participation Questionnaire

1. Name _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
2. Please describe in detail your current exercise program. Please specify the
activity, amount per day, days per week, and the length oftime you have been
training at this level

3. Have you recently experienced an illness or injury that has required you to take
time off from training? If yes, please explain.

4. Have you previously taken dietary supplements (protein powder, creatine, amino
acids, etc.)? If yes, please specify.

5. Are you currently taking dietary supplements? If yes, please specify.
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APPENDIXC
Subject Informed Consent
ritle of the research study: The effects of glutamine supplementation on maximal
perfonnance and recovery from high-intensity exercise.
IRE assigned number: 07.0174
Investigator(s) name & address: Jacks, Dean, Department of Health & Sport Sciences
University of Louisville Crawford Gym, Room 114Louisville, Kentucky 40292
Site(s) where study is to be conducted: Belknap Campus Laboratory, Laboratory
Phone number for subjects to callfor questions: Dean Jacks, Ph.D. at (502) 852-8352.
Introduction and Background Information
You are invited to take part this research study because you are 18-30 years of age and
participate in thirty minutes of moderate to high-intensity aerobic exercise at least four
days a week. In addition, you are free of metabolic, cardiovascular, and orthopedic
limitations. The study is being conducted under the direction of Dean Jacks, Ph.D.,
Assistant Professor for the Department of Health & Sport Sciences and Mandy Jacobs,
B.S., graduate student. Approximately twelve local subjects will be invited to participate.
Your participation in this study will consist of three separate sessions on three different
days.
Purpose
The purpose of this study is to investigate the effects of glutamine supplementation on
maximal perfonnance during high-intensity exercise and on recovery from high-intensity
exercise.
Procedures
Your participation in this study will consist of three separate sessions. You will be asked
to abstain from any dietary supplementation and maintain current levels of exercise for
the duration of the study. The first session will last approximately one-hour and will
consist of completing a health survey and questionnaire which ask about your physical
activity habits, supplementation history and recent illness and/or injuries. You may
decline to answer any questions that make you feel uncomfortable. To assess general and
overall body composition, height, weight, and skin folds will be taken. In addition, your
resting heart rate and blood pressure will be measured. You will then be asked to
complete and tum in a 3-day food diary before the first day of exercise testing. The food
diary should include dietary intake for two weekdays and one weekend day. We will
explain how to complete the food diary at the end of the first session and give you
examples to take home.
The second and third sessions will last approximately 4 hours and a minimum of 7 days
should exist between the second and third testing session. You will be asked to fast 2-
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hours prior to reporting the laboratory for each testing session. In addition, you will be
asked not to perfonn any exercise prior to reporting to the laboratory. Before the second
testing session, you will be randomly assigned to one of two treatments, however you
will not be infonned as to which treatment you have been assigned. Treatment
assignments will be made using randomization which is a process similar to "flipping a
coin". One group will participate in the experimental condition during the second testing
session and the control condition the third testing session. The second group will
participate in the control condition during the second testing session and the experimental
condition during the third testing session.
Upon reporting to the laboratory for the second and third testing sessions, we will
measure your resting blood pressure and heart rate. A research registered nurse trained
and credentialed in intravenous catheter placement will then insert a temporary catheter
into a vein on the back of your hand. The catheter is similar to an intravenous catheter
used to collect blood samples and administer intravenous medications. This catheter will
be used to draw blood before exercise, during exercise and after exercise testing. A
maximum of ten blood samples will be obtained throughout each testing session. The
blood samples will be allowed to clot and then centrifuged for 20-30 minutes in order to
separate the serum from the cellular components. The serum will then be pipette
transferred to storage tubes and stored at -70F for future analysis. Specifically, we will be
analyzing the blood samples for glutamine, glutamate, alanine and lactate concentrations.
The samples will be stored for approximately 7 months before analysis is conducted.
After analysis is conducted, blood samples will be destroyed.
You will then be asked to drink 0.03 g/kg of body weight of glutamine mixed with 250
ml of caffeine-free fruit juice or 250 ml of caffeine-free fruit juice (placebo). You will be
given IO-minutes to consume the drink, which will be premixed by a research assistant.
You will then rest for I-hour in the sitting position. After I-hour you will perfonn a
maximal exercise test on the treadmill. The exercise test will consist of incremental
increases in workload and is designed to induce fatigue within 8-14 minutes. Upon
completion ofthe exercise test you will be asked to sit in a chair for I-hour. In order to
measure expired gases during and after the exercise test, you will be asked to wear a
headpiece and mouthpiece that is comparable to a snorkel. At the commencement of 1hour, a research nurse will remove the catheter from your hand and a research assistant
will remove the headpiece and mouthpiece. Additionally, you will be asked to provide a
urine sample pre-and post-exercise. All blood and urine samples will be de-identified
(your name will not be linked to the samples), thus if you withdraw from the study,
specimens cannot be destroyed.
Potential Risks
There are known physical risks linked with high-intensity exercise. Physical risks
include elevated heart rate, muscle fatigue, and shortness of breath. In rare instances,
high-intensity exercise may lead to cardiac events and/or death. It is likely (greater than
40%) that you will experience elevated heart rate, muscle fatigue and shortness of breath.
In rare instances (less than 1%) high-intensity exercise may lead to cardiac events
and/or death. There are known physical risk linked with having blood drawn. Risk may
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include excessive bleeding, fainting or feeling light headed, hematoma (blood
accumulating under the skin) and infection. To date, oral supplementation of glutamine
have not demonstrated any side effects when taken in small dosages. Glutamine has
shown to be well tolerated in healthy subjects when administered orally in small dosages
and is readily metabolized and cleared from the body. Non physical risk (psychological,
social, economic, legal) are not anticipated with this study. However, you may suffer
harms that we have not seen before.

Benefits
It is not clear that you will benefit directly from this study, but it is hoped that your
participation will help others in the future.

Alternatives
Instead of taking part in this study, you could choose to not participate as a subject in this
study.

Research Related Injury
If you are injured by being in this research study, the study doctor will arrange for you to
get medical treatment. The sponsor, the study site, or your study doctor has not set aside
money to pay for treatment of any injury. You and your insurance will be billed for the
treatment of these injuries. Before you agree to take part in this research study you should
find out whether your insurance will cover an injury in this kind of research. You should
talk to the study doctor or staff about this. If you are injured, there is no money set aside
for lost wages, discomfort, disability, etc. You do not give up your legal rights by signing
this form. If you think you have a research related injury, please call your study doctor.

Compensation
You will not be compensated for your time, inconvenience, or expenses while you are in
this study.

Costs
There will be no additional costs to you for participating. However, you.or your insurance
company will be billed for all office visits and procedures that are part of routine medical
care. It is your responsibility to find out what costs, if any, your insurance company will
cover before taking part in the study.

HIPAA Research Authorization
The Health Insurance Portability and Accountability Act of 1996 (HIP AA) provides
federal safeguards for protected health information (PHI). Examples of PHI are your
name, address, and birth date. PHI may also include your medical history, results of
health exams and lab tests, drugs taken and results of this research study. Your PHI
cannot be used or shared without your agreement, unless it meets one of the HIP AA
exceptions. You will be asked to sign a "Research Authorization" form. This allows the
use and sharing of your PHI by those listed in the "Research Authorization."

Confidentiality
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Total privacy cannot be guaranteed. We will protect your privacy to the extent pennitted
by law. If the results from this study are published, your name will not be made public.
The following may look at your research and medical records:
*The University of Louisville Institutional Review Board, Human Subjects Protection
Program Office, Privacy Office and others involved in research administration at the
University.
*People who are responsible for research and HIP AA oversight at the institutions where
the research is conducted.
-Government agencies, such as: Office for Human Research Protections (OHRP), Office
of Civil Rights, and other appropriate regulatory government agencies.

Security
All data will be protected from disclosure by being kept in a locked file and all
identifying infonnation will be excluded from data fonns. In addition, blood and urine
samples will be de-identified (your name will not be linked to the samples), thus if you
withdraw from the study, specimens cannot be destroyed.

Voluntary Participation
Taking part in this study is completely voluntary. You may choose not to take part at all.
If you decide not to be in this study, you won't be penalized or lose any benefits for
which you qualify. If you decide to be in this study, you may change your mind and stop
taking part at any time. If you decide to stop taking part, you won't be penalized or lose
any benefits for which you qualify. You will be told about any new infonnation learned
during the study that could affect your decision to continue in the study.

Termination
Your study doctor has the right to stop this study at any point. Your study doctor may
take you out of this study with or without your okay. Reasons why this may occur
include: failure to follow the experimental procedures and instructions provided by the
investigators and failure to attend the experimental sessions. If you wish to withdraw
from the study, there will be no consequences to you. We only ask that you tell us of your
desire to stop participation in the study and you will be immediately withdrawn from the
study.

Participation in Other Research Studies
You may not take part in this study if you are currently in another research study. It is
important to let your doctor know if you are in another research study.

Contact Persons
Dean Jacks, Ph.D. at (502) 852-8352.

Research Subject's Rights
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at (502) 852-5188. You can discuss any
questions about your rights as a research subject, in private, with a member of the
Institutional Review Board (IRB).
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You may also call this number if you have other questions about the research, and you
cannot reach the study doctor, or want to talk to someone else. The IRB is an independent
committee made up of people from the University community, staff of the institutions, as
well as people from the community not connected with these institutions. The IRB has
reviewed this research study.

Concerns and Complaints
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call 1-877-852-1167. This is a 24 hour hot line
answered by people who do not work at the University of Louisville.
Acknowledgment and Signatures
This informed consent document is not a contract. This document tells you what will
happen during the study if you choose to take part. Your signature indicates that this
study has been explained to you, that your questions have been answered, and that you
agree to take part in the study. You are not giving up any legal rights by signing this
informed consent document. You will be given a signed copy of this consent form to
keep for your records.
Do you want your primary care physician notified that you are a subject in this study?
DYes DNo

Printed Name of Subject/Legal Representative

Signature of Subject/Legal Representative

Date Signed

Printed Name of Person Explaining Consent Form Signature of Person Explaining Consent Form
(if other than investigator)

Date Signed

Printed Name ofInvestigator

Date Signed

Signature of Investigator

*Note: If the investigator is not the person explaining the consent form, then the
investigator must sign the Informed Consent Document within two weeks of the subject or
subject's legal representative.

Specimen Informed Consent
Title of the research study: The effects of glutamine supplementation on maximal
performance and recovery from high-intensity exercise.
IRE assigned number: 07.0174
Investigator(s) name & address: Jacks, Dean, Department of Health & Sport Sciences
University of Louisville Crawford Gym, Room 114Louisville, Kentucky 40292
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SUe(s) where study is to be conducted: Belknap Campus Laboratory, Laboratory
Phone number for subjects to call for questions: If you have any questions, concerns, or
complaints about the research study, please contact Dean Jacks at (502) 852-8352.

Introduction and Background Information
You are invited to participate in a research study. The study is being conducted by Dr.
Dean Jacks, Ph.D., Assistant Professor for the Department of Health & Sport Sciences
and Mandy Jacobs, B.S, graduate student. The study is sponsored by the University of
Louisville, Department of Health & Sport Sciences. The study will take place at
Crawford Gym on Belknap Campus. Approximately 12 local subjects will be invited to
participate. Your participation in this study will consist of three separate sessions on three
different days.
Purpose
The purpose of this research study is to investigate the effects of glutamine
supplementation on maximal performance during high-intensity exercise and on
recovery from high-intensity exercise. Glutamine is an amino acid that is found in most
naturally occurring food proteins.
Procedures
A research registered nurse trained and credentialed in intravenous catheter placement
will insert a temporary catheter into a vein on the back of your hand. The catheter is
similar to an intravenous catheter used to collect blood samples and administer
intravenous medications. Approximately 5.5 tablespoons of blood will be removed from
your vein for the experimental purpose of determining the concentrations of various
amino acids (glutamine, alanine, glutamate) and lactate, which is a byproduct of exercise.
A tourniquet will be placed on your arm, a needle placed in your vein, and approximately
5.5 tablespoons of blood will be removed. The blood will be removed intermittently,
meaning not all of the blood will be removed at once. About 1.5 teaspoons of blood will
be removed at a time, resulting in a maximum of 10 separate blood draws. The blood
samples will be allowed to clot and then centrifuged for 20-30 minutes in order to
separate the serum from the cellular components. The serum will then be pipette
transferred to storage tubes and stored at -70F for future analysis. In addition, you will be
asked to provide a urine sample pre- and post-exercise testing. The samples will be
stored for approximately 7 months before analysis is conducted. All samples will be deidentified (your name will not be linked to the samples), thus if you withdraw from the
study, specimens cannot be destroyed. Once all analyses have been conducted, the
samples will be destroyed.

Risks
There may be some pain or discomfort during the procedure. It is possible there may be
some bleeding, bruising or infection at the puncture site.
Benefits
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The possible benefits of this study include more infonnation about the efficacy of
glutamine as an ergogenic aid. The infonnation collected may not benefit you directly.
The infonnation learned in this study may be helpful to others.

Compensation
You will not be compensated for your time, inconvenience, or expenses while you are in
this study.
Costs
There will be no additional costs to you for participating. However, you or your insurance
company will be billed for all office visits and procedures that are part of routine medical
care. It is your responsibility to find out what costs, if any, your insurance company will
cover before taking part in the study.
HIPAA Research Authorization
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) provides
federal safeguards for protected health infonnation (PHI). Examples of PHI are your
name, address, and birth date. PHI may also include your medical history, results of
health exams and lab tests, drugs taken and results of this research study. Your PHI
cannot be used or shared without your agreement, unless it meets one of the HIP AA
exceptions. You will be asked to sign a "Research Authorization" fonn. This allows the
use and sharing of your PHI by those listed in the "Research Authorization."

Security
All data will be protected from disclosure by being kept in a locked file and all
identifying
infonnation will be excluded from data fonns. In addition, blood and urine samples will
be de-identified (your name will not be linked to the samples), thus if you withdraw from
the study, specimens cannot be destroyed.
Voluntary Participation
Taking part in this study is completely voluntary. You may choose not to take part at all.
If you decide not to be in this study, you won't be penalized or lose any benefits for
which you qualify. If you decide to be in this study, you may change your mind and stop
taking part at any time. If you decide to stop taking part, you won't be penalized or lose
any benefits for which you qualify.
Termination
Your study doctor has the right to stop this study at any point. Your study doctor may
take you out of this study with or without your okay. Reasons why this may occur
include: failure to follow the experimental procedures and instructions provided by the
investigators and failure to attend the experimental sessions. If you wish to withdraw
from the study, there will be no consequences to you. We only ask that you tell us of your
desire to stop participation in the study and you will be immediately withdrawn from the
study.
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Participation in Other Research Studies
You may not take part in this study if you are currently in another research study. It is
important to let your doctor know if you are in another research study.
Confidentiality
Total privacy cannot be guaranteed. We will protect your privacy to the extent permitted
by law. If the results from this study are published, your name will not be made public.
The following may look at your research and medical records:
*The University of Louisville Institutional Review Board, Human Subjects Protection
Program Office, Privacy Office and others involved in research administration at the
University.
*People who are responsible for research and HIP AA oversight at the institutions where
the research is conducted.
*Government agencies, such as: Office for Human Research Protections (OHRP),
Office of Civil Rights, and other appropriate regulatory government agencies.

Contact Persons
If you have any questions, concerns, or complaints about the research study, please
contact Dean Jacks at (502) 852-8352.

Research Subject's Rights
If you have any questions about your rights as a research subject, you may call the
Human Subjects Protection Program Office at (502) 852-5188. You can discuss any
questions about your rights as a research subject, in private, with a member ofthe
Institutional Review Board (IRB). You may also call this number if you have other
questions about the research, and you cannot reach the study doctor, or want to talk to
someone else. The IRB is an independent committee made up of people from the
University community, staff of the institutions, as well as people from the community not
connected with these institutions. The IRB has reviewed this research study.

Concerns and Complaints
If you have concerns or complaints about the research or research staff and you do not
wish to give your name, you may call 1-877-852-1167. This is a 24 hour hot line
answered by people who do not work at the University of Louisville ..

Acknowledgment and Signatures
This informed consent document is not a contract. This document tells you what will
happen during the study if you choose to take part. Your signature indicates that this
study has been explained to you, that your questions have been answered, and that you
agree to take part in the study. You are not giving up any legal rights by signing this
informed consent document. You will be given a signed copy of this consent form to
keep for your records.
Printed Name of Subject/Legal Representative

Signature of Subject/Legal Representative

Printed Name of Person Explaining Consent Form Signature of Person Explaining Consent Form
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Date Signed

Date Signed

(if other than investigator)

Printed Name of Investigator

Signature of Investigator

Date Signed

*Note: If the investigator is not the person explaining the consent form, then the
investigator must sign the Informed Consent Document within two weeks of the subject or
subject's legal representative.

Consent version date: 1112612007
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APPENDIXD

•

•

•
•
•
•

Instrnctions for 3-Day Nutritional Diary
Record everything you consume for 3 days (1 weekend day, 2 week days) in the
logs provided. Be sure to include the date on each dietary log.
'Amount' - In this space indicate the amount of the particular food/drink item
you ate/drank. Estimate the size (2"x 1"x 1"), the volume (112 cup), the weight (2
ounces) and/or the number of items (12) of that type of food/drink.
'What Kind' - In this column, write down the type of food/drink you ate/drank.
Don't forget to write down extras, such as candy, butter, alcohol and sugar.
'Brand' - In this space indicate the brand of the particular food/drink you
ate/drank.
'Time' - Write down the time of day you ate/drank the food/drink.
Be sure to note if you were taking any medication, vitamins, supplements, etc. in
the space provided.

Tips for Keeping a Nutritional Diary
1. Write down EVERYTHING
Keep your form with you all day and write down everything you eat and drink. A
piece of candy, a handful of pretzels, a can of soda or small cookie may not seem like
much at the time, but over 3 days these calories add up.
2. DoitNOW
Don't depend on your memory at the end of the day. Record your eating/drinking as
you go.
3. Be SPECIFIC
Make sure to include extras, such as ketchup, salad dressing, gravy, pickles on your
sandwich, etc. Also include how the item was prepared - fried, baked, breaded,
scrambled, steamed, etc.
4. Estimate amounts
Remember, a fist = 1 cup; palm or deck of cards = 3 oz.; handful = 1-2 oz.
5. Tell the Truth
There's nothing to be gained by trying to look good on these forms. Do not change
your eating habits while you're keeping your food diary.
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Three- D ay Nt"
u ntionaID'larr
Food or Drink
Amount
What Kind

Brand

SupplementsNitamins/Medications (BE SPECIFIC):
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Time

APPENDIXE

Treadmill Protocol
TIME
(minutes)
3

SPEED
(mph)

GRADE(%)

6

1.7
2.5

9

3.4

12
15
18

4.2
5.0
5.5

4.0
6.5
10.0
12.5
15.0
17.5
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APPENDIXF
Category Scale for Ratings of Perceived Exertion

6
7

Very, very light

8
9

Very light

10
11

Fairly light

12
13

Somewhat hard

14
15

Hard

16
17

Very hard

18
19

Very, very hard

20
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APPENDIXG
Power & Sample Size Analysis
Power Ana1ysis*
Sample Size Ca1cu1ation#
n = 7 (6 males & 1 female)
V02max
0.078
19
5-minP V0 2
0.059
60
25
0.071
10-minP V0 2
19
30-minP V02
0.077
60-minP V02
0.096
11
0.057
42
Stage 1 CO2
0.096
12
Stage 2 C02
Stage 3 CO2
.253
3
14
Stage 4 C02
0.088
5-minP C02
0.058
65
12
10-minP C02
0.094
54
30-minP CO2
0.060
22
60-minP C02
0.074
466
Max RER
0.051
1
5-minP RER
0.551
5
0.155
lO-minP RER
23
30-minP RER
0.072
14
60-minP RER
0.087
5
0.153
3-minE HR
10
0.101
6-minE HR
17
0.080
9-minE HR
4
0.673
12-minE HR
39
0.063
EndHR
4024
0.050
I-minP HR
603
0.051
3-minP HR
X
5-minP HR
X
170
lO-minP HR
0.053
12
0.096
30-minP HR
331
0.052
60-minP HR
28
0.069
3-minE RPE
36
0.064
6-minE RPE
20
0.077
9-minE RPE
186
0.053
12-minE RPE
5
0.168
EndRPE
10
0.102
Pre Urine
124
0.054
Post Urine
333
0.052
Pre Saliva
11
0.100
Post Saliva
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n = 6 (Males)
Power Analysis
Sample Size Calculation
V02max
0.071
21
5-minP V0 2
0.065
29
lO-minP V0 2
0.11
8
30-minP V0 2
18
0.075
60-minP V0 2
34
0.063
Stage 1 CO2
0.080
15
Stage 2 CO2
0.108
8
Stage 3 CO2
0.252
2
Stage 4 CO2
0.105
13
5-minP CO2
0.058
56
lO-minP CO2
0.117
7
30-minP CO2
0.065
29
60-minP CO2
548
0.051
MaxRER
0.051
573
5-minP RER
0.552
1
lO-minP RER
2
0.255
30-minP RER
2
0.065
60-minP RER
4
0.156
3-minE HR
X
X
6-minE HR
7
0.118
9-minEHR
0.071
18
12-minE HR
0.155
4
EndHR
16
0.078
I-minP HR
0.061
40
3-minP HR
95
0.055
5-minP HR
X
X
lO-minP HR
251
0.052
30-minP HR
17
0.077
60-minP HR
589
0.051
21
3-minE RPE
0.071
6-minE RPE
27
0.066
22
9-minE RPE
0.071
12-minE RPE
186
0.052
I
EndRPE
0.369
Pre Urine
33
0.063
143
Post Urine
0.053
118
Pre Saliva
0.059
4
Post Saliva
0.158
V02= volume of 02 consumption; P = post-exercise; Stage 1 = average of minutes 2-3;
Stage 2 = average of minutes 5-6; Stage 3= average of minutes 8-9; Stage 4= average of
minutes 11-12; E = during exercise; End = upon completion of exercise; Pre = I-hour
post-ingestion; Post = I-hour post exercise; X = could not calculate; * a = 5%; # p:= 80%
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